Marcel Wiesweg

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.3K citations · Full text

Advanced Lung Cancer, Cancer Immunosurveillance, Medicine +12

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Henning Reis, Martin Metzenmacher, Moritz Goetz et al. · Clinical Lung Cancer · 2018 · 106 citations

Met Expression, Medicine, Metronomic Therapy +8

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Melanie Janning, Juliane Süptitz, Corinna Albers et al. · Annals of Oncology · 2022 · 87 citations · Full text

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Martin Schüler, Kristof Cuppens, Till Plönes et al. · Nature Medicine · 2024 · 70 citations · Full text

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Marcel Wiesweg, Wilfried Eberhardt, Henning Reis et al. · Journal of Thoracic Oncology · 2016 · 68 citations

Oncology, Somatic Variant, Concomitant Oncogene Mutations +10